< Back to Results

Primary Contact Name
Blachy Davila
Primary Contact Email Address
BJDAVILA@CHILDRENSNATIONAL.ORG
Primary Contact Phone Number
2024766690
Program Name
Bone Marrow Transplant and Cellular Therapy Fellowship
Address
111 Michigan Ave NW
Washington, DC, 20017
Website
https://www.childrensnational.org/for-healthcare-professionals/healthcare-education/graduate-medical-education/residencies-and-fellowships/bmtct-fellowship
Program Director/Fellowship Director
Blachy Davila
Program Director/Fellowship Director Email
BJDAVILA@CHILDRENSNATIONAL.ORG
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
BTH
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
Yes
Is the primary focus of your program on adult or pediatric populations?
Pediatric
How long before the Fellowship start date should applicants apply?
7-12 Months
When does your Fellowship application period begin?
June
When does your Fellowship application period end?
November
Interview required?
Yes
Interview Format
Flexible
How many training spaces?
Two
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
July
If flexible, please describe
Not Provided
Visa Sponsorship?
Yes
If you selected yes, please specify the type of visa
Other
What are the requirements for fellows applying to your program?
Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible), Eligibility to obtain a State Medical License
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
Rotating at both children's and the nih is unique and very educational to fellows. At CNH, we have a robust cellular therapy research platform that involves commerical and research CAR-T, first and third party CTL's against viruses, solid tumors, and leukemia/ MDS, among others. Fellows may rotate through the CTL lab as part of their elective time. We offer robust numbers and specialized teams in high risk leukemia, neuro oncology, sickle cell and primary immunodeficiencies, among other disorders.
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
30
Allogeneic Transplant
60(At CNH, similar number at NIH)
CAR T
5 (plus multiple other opportunities at NIH)
Approximate Structure (In weeks)
Inpatient
17
Outpatient/Consults
17
Research
18
Lab-Based
0
Other (specify)
elective time can be modified as preferred by the fellow
Sample Schedule Upload
Not Provided
Educational Stipend/Conference funding available:
Yes - Specify
Specify the Educational Stipend/Conference funding available
variable; both CNH and NIH funding plus application for extra funds for presentations available
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Application Open

< Back to Results